These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10191232)

  • 1. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection.
    Lesens O; Deschênes M; Steben M; Bélanger G; Tsoukas CM
    J Infect Dis; 1999 May; 179(5):1254-8. PubMed ID: 10191232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV.
    Rockstroh JK; Spengler U; Sudhop T; Ewig S; Theisen A; Hammerstein U; Bierhoff E; Fischer HP; Oldenburg J; Brackmann HH; Sauerbruch T
    Am J Gastroenterol; 1996 Dec; 91(12):2563-8. PubMed ID: 8946987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.
    Daar ES; Lynn H; Donfield S; Gomperts E; O'Brien SJ; Hilgartner MW; Hoots WK; Chernoff D; Arkin S; Wong WY; Winkler CA;
    J Infect Dis; 2001 Feb; 183(4):589-95. PubMed ID: 11170984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
    J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection.
    Ragni MV; Belle SH
    J Infect Dis; 2001 Apr; 183(7):1112-5. PubMed ID: 11237838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C in hemophiliacs.
    Franchini M; Nicolini N; Capra F
    Am J Hematol; 2006 Sep; 81(9):696-702. PubMed ID: 16838339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.
    Yoo TW; Donfield S; Lail A; Lynn HS; Daar ES;
    J Infect Dis; 2005 Jan; 191(1):4-10. PubMed ID: 15592996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.
    Goedert JJ; Hatzakis A; Sherman KE; Eyster ME;
    J Infect Dis; 2001 Nov; 184(9):1202-5. PubMed ID: 11598846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
    Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
    Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.
    Pereira GA; Stefani MM; Martelli CM; Turchi MD; Siqueira EM; Carneiro MA; Martins RM
    J Med Virol; 2006 Jun; 78(6):719-23. PubMed ID: 16628586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
    Roe B; Coughlan S; Hassan J; Grogan A; Farrell G; Norris S; Bergin C; Hall WW
    J Infect Dis; 2007 Oct; 196(7):1053-7. PubMed ID: 17763328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children.
    Micheloud D; Jensen J; Bellón JM; Gurbindo D; de José MI; Moreno D; Ramos JT; Muñoz-Fernández MA; Resino S;
    Pediatr Infect Dis J; 2007 Sep; 26(9):846-9. PubMed ID: 17721385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
    Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
    Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
    Merchante N; Macías J; Ramayo E; Vergara S; García-García JA; Mira JA; Corzo JE; Gómez-Mateos JM; Lozano F; Pineda JA
    J Viral Hepat; 2006 Jul; 13(7):449-56. PubMed ID: 16792538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
    J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.